Growing market Llorens Pharmaceutical has demonstrated significant growth with expansion of product lines in Puerto Rico and the United States, presenting opportunities to cross-sell formulation, development, and manufacturing services to new and existing distributors and retailers.

Integrated capabilities Full in-house testing and multiple manufacturing departments (R&D, QA, Regulatory, QC) enable end-to-end product development and stability testing, offering potential as a turnkey partner for contract development and manufacturing opportunities.

Private manufacturing New Miami manufacturing plant positions Llorens as a domestic production partner, presenting a compelling value proposition for US-based supply chain resilience, quick-turn projects, and potential FDA-registered facility collaborations.

Regulatory readiness Licensing across Local, State, and Federal agencies including List 1 chemical manufacturing indicates capability to handle regulated and sensitive pharmaceutical products, suggesting opportunities in compliance-heavy contract manufacturing and distribution.

Portfolio expansion Experience across prescription and OTC markets with products from common cold to gastric bypass implies openness to strategic partnerships for formulation development, private labeling, and accelerated market entry for partner brands.